Stegent Equity Advisors Inc. Reduces Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Stegent Equity Advisors Inc. lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 30.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,728 shares of the financial services provider’s stock after selling 2,101 shares during the quarter. Stegent Equity Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $688,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Global Assets Advisory LLC purchased a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth about $66,059,000. BNP Paribas Financial Markets increased its stake in shares of iShares Biotechnology ETF by 25.7% during the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares in the last quarter. Jane Street Group LLC purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $14,386,000. Cetera Investment Advisers boosted its position in shares of iShares Biotechnology ETF by 689.4% in the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after purchasing an additional 79,541 shares in the last quarter. Finally, State of Michigan Retirement System grew its stake in shares of iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after buying an additional 75,000 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 0.2 %

NASDAQ:IBB traded up $0.22 during trading hours on Friday, reaching $145.91. 815,270 shares of the company traded hands, compared to its average volume of 1,466,877. The business’s 50-day moving average price is $145.65 and its two-hundred day moving average price is $139.69. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.